Antibodies, thrombosis and the endothelium

Rheumatology

Volumn 33, Issue 1, 1994, Pages 2-4

  D'cruz, D ^a   Hughes, G ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LUPUS ANTICOAGULANT; PROSTACYCLIN; PROTEIN C; PROTEIN S;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; BLOOD CLOTTING DISORDER; EDITORIAL; ENDOTHELIUM; ETIOLOGY; FIBRINOLYSIS; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ADHESION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANTIBODIES, ANTIPHOSPHOLIPID; ENDOTHELIUM, VASCULAR; HUMAN; THROMBOSIS;

EID: 0028054864     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/33.1.2     Document Type: Editorial

References (27)

1. Hughes GRV. The antiphospholipid syndrome—10 years on. Lancet 1993;342:341-44.
2. Blank MJ, Cohen V, Toder V, Schonfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci, USA 1991; 88:3069-73.
3. Branch DW, Dudley DJ, Mitchell MD et al. Immunoglobulin G fractions from patients with anti-phos-pholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynaecol 1990;163:213-16.
4. McNeil HP, Simpson R, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor or coagulation: B2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci, USA 1990;87:4120-4.
5. Ichikawa K, Khamashta MA, Hughes GRV. Specificity of monoclonal anti-cardiolipin antibodies from patients with antiphospholipid syndrome. Arthritis Rheum 1992;35 (suppl):69.
6. Carreras LO, Vermylen JG. ‘Lupus’ anticoagulant and thrombosis—possible role of inhibition of prostacyclin formation. Thromb Haemostas 1982;48:38-40.
7. Watson KV, Schorer AE. Lupus anticoagulant inhibition of in-vitro protacyclin release is associated with a thrombosis-prone subset of patients. Am J Med 1991; 90:47-53.
8. Hasselaar P, Derksen RH WM, Blokzijl L, DeGroot PG. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial cell—platelet prostanoid synthesis. Thromb Haemostas 1985;59:80-5.
9. Tsakiris DA, Marbet GA, Makris PE, Settas L, Duckert E Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant. Thromb Haemostas 1989;69:175-7.
10. Escolar G, Font J, Reverter JC et al. Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system. Arterioscler Thromb 1992;12:196-200.
11. Boey ML, Loizou S, Colaco B, Matkin JA, Hughes GRV. Antithrombin III in systemic lupus erythematosus. Clin Exp Rheumatol 1984;2:53-6.
12. Dahlback B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemostas 1991;66: 49-61.
13. Cariou R, Tobelem G, Beilud S et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells—inhibition of thrombomodulin— dependent protein C activation. Thromb Haemostas 1988;60:54-8.
14. Marciniak E, Romond EH. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood 1989;74:2426-32.
15. Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990; 76:101-7.
16. Borrell M, Sala N, de Castellarnau C, Lopez S, Gari M, Fontcuberta J. Immunoglobulin fractions isolated from patients with anti-phospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells. Thromb Haemostas 1992;68:268-72.
17. Lindsey NJ, Henderson FI, Malia R, Milford Ward MA, Greaves M, Hughes P. Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis prone patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 1994;33:00-00.
18. Tsakiris DA, Settas L, Makris PE, Marbet GA. Lupus anticoagulant—antiphospholipid antibodies and thrombophilia. Relation to protein C-protein S-thrombomodulin. J Rheumatol 1990;17:785-9.
19. Oosting JD, Derksen RHW, Hackeng TM et al. In vitro studies of antiphospholipid antibodies and its co-factor B2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation. Thromb Haemostas 1992;66:666-71.
20. Walker TS, Triplett DA, Javed N, Musgrave K. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion and antigenic protein S levels. Thrombosis Res 1988;51:267-81.
21. Lloyd ME, D’Cruz D, McAlindon TE, Hunt B, Hughes GRV. Free protein S levels and thrombosis in systemic lupus erythematosus. Arthritis Rheum 1993; 36 (suppl.):D247.
22. Cervera R, Khamashta MA, Font J et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991;11:1-6.
23. McCrae KR, DeMichele P, Samuels P et al. Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 1991;79:595-605.
24. D’Cruz DP. Novel antibodies in vasculitis In: Khamashta MA, Font J, Hughes GRV, eds. Autoimmune connective tissue diseases. Barcelona: Doyma; 1993: 163-75.
25. Haaselaar P, Derksen RHWM, Blokzijl L, DeGroot PG. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemostas 1990;63:169-73.
26. van der Zee JM, Siegert CEH, De Vreede TA, Daha MR, Breedveld FC. Characterization of anti-endo-thelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1991;84:238-44.
27. D’Cruz DP, Khamashta MA, Hughes GRV. Characterization of anti-endothelial cell antibody binding in lupus nephritis. Br J Rheumatol 1993;32:(suppl.1)23.